NEWS

Clinical Research MOSCOW–(Marketwired – Apr 16, 2013) – Cromos Pharma, an international full service contract research organization (CRO), announced today that it opened an office in the Republic of Georgiа. A word from our CEO: “Georgia is a very important location for Cromos Pharma,” noted Dr. Vladimir Bogin, Chief Executive Officer of Cromos Pharma. “Some of the

Video of Cromos™ Pharma’s CEO participation in round table on our charitable work under the auspices of nonprofit organization, Stand Up To Cancer

Cromos™ Pharma helps Regen Biopharma in filing of an Investigational New Drug (IND) application with the FDA

Cromos™ Pharma will participate in 2012 BIO International Convention in Boston, MA, USA on 18-21 June 2012 Cromos™ Pharma will participate in 2012 BIO International Convention that will be held at Boston Convention and Exhibition Center on 18-21 June 2012. If you would like to schedule 1-2-1 meeting with Cromos™ Pharma’s management during the event please email Dr Vladimir Bogin.

CEO, Dr. Vlad Bogin collaborates on a scientific publication describing stem cell treatment of a spinal cord injury patient ABSTRACT: Cellular therapy for spinal cord injury (SCI) is overviewed focusing on bone marrow mononuclear cells, olfactory ensheathing cells, and mesenchymal stem cells. A case is made for the possibility of combining cell types, as well as for allogeneic use. We report the case of 29 year old male who suffered a crush fracture of

CEO, Dr. Vlad Bogin collaborates on a scientific publication describing new gene responsible for heart damage in diabetics